Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1658-1664

  Masselot, F ^a   Boulos, A ^a   Maurin, M ^a   Rolain, J M ^a   Raoult, D ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; ESCHERICHIA COLI; FEMALE; GENE IDENTIFICATION; GYRA GENE; HUMAN; HUMAN CELL; INTESTINE LIPODYSTROPHY; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; SUPERNATANT; TROPHERYMA WHIPPELII;

ACTINOBACTERIA; AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; WHIPPLE DISEASE;

EID: 0037997057     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1658-1664.2003     Document Type: Article

References (34)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Badak, F. Z., S. Goksel, R. Sertoz, A. Guzelant, A. Kizirgil, and A. Bilgic. 1999. Cord formation in MB/BacT medium is a reliable criterion for presumptive identification of Mycobacterium tuberculosis complex in laboratories with high prevalence of M. tuberculosis. J. Clin. Microbiol. 37:4189-4191.
3. Calcutt, M. J. 1994. Gene organization in the dnaA-gyrA region of the Streptomyces coelicolor chromosome. Gene 151:23-28.
4. Cullen, M., A. Wyke, R. Kuroda, and L. Fisher. 1989. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob. Agents Chemother. 33:886-894.
5. Drancourt, M., A. Carlioz, and D. Raoult. 2001. rpoB sequence analysis of cultured Tropheryma whippelii. J. Clin. Microbiol. 39:2425-2430.
6. Drlica, K. 1999. Mechanism of fluoroquinolone action. Curr, Opin. Microbiol. 2:504-508.
7. Fenollar, F., and D. Raoult. 2001. Molecular techniques in Whipple's disease. Expert Rev. Mol. Diagn. 1:299-309.
8. Guillemin, I., V. Jarlier, and E. Cambau. 1998. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob. Agents Chemother. 42:2084-2088.
9. Guillemin, I., W. Sougakoff, E. Cambau, V. Revel-Viravau, N. Moreau, and V. Jarlier. 1999. Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum. Microbiology 145:2527-2532.
10. Herrera, G., V. Aleixandra, A. Urios, and M. Blanco. 1993. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations. FEMS Microbiol. Lett. 106:187-191.
11. Higgins, D. G., and P. M. Sharp. 1988. Clustal: a package for performing multiple sequence alignment on a microcomputer. Gene 73:237-244.
12. Hinrikson, H. P., F. Dutly, and M. Altwegg. 2000. Evaluation of a specific nested PCR targeting domain III of the 23S rRNA gene of "Tropheryma whippelii" and proposal of a classification system for its molecular variants. J. Clin. Microbiol. 38:595-599.
13. Houssaye, S., L. Gutmann, and E. Varon. 2002. Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:2712-2715.
14. Huang, W. M. 1996. Bacterial diversity based on type II DNA topoisomerase genes. Annu. Rev. Genet. 30:79-107.
15. James, B. W., A. Williams, and P. D. Marsh. 2000. The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium. J. Appl. Microbiol. 88:669-677.
16. Kocagoz, T., C. J. Hackbarth, I. Unsal, E. Y. Rosenberg, H. Nikaido, and H. F. Chambers. 1996. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40:1768-1774.
17. Kumagai, Y., J. I. Kato, K. Hoshino, T. Akasaka, K. Sato, and H. Ikeda. 1996. Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrob. Agents Chemother. 40:710-714.
18. La Scola, B., F. Fenollar, P. E. Fournier, M. Altwegg, M. N. Mallet, and D. Raoult. 2001. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int. J. Syst. Evol. Microbiol. 51:1471-1479.
19. Mateos-Colino, A., C. Falo Zamora, M. Maner, and P. Fernandez-Viladrich. 1996. Sindrome febril y derrame pleural aislado como presentacion de fiebre Q. Rev. Clin. Espanola 196:78-79. (In Spanish.)
20. Musser, J. M. 1995. Antimicrobial agents resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
21. Oram, M., and L. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
22. Pan, X. S., and L. M. Fisher. 1996. Cloning and characterization of the parC and pare genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
23. Pan, X. S., P. J. Hamlyn, R. Talens-Visconti, F. L. Alovero, R. H. Manzo, and L. M. Fisher. 2002. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. Antimicrob. Agents Chemother. 46:2498-2506.
24. Piddock, L. J. 1999. Mechanisms of fluoroquinolone resistance: an Update 1994-1998. Drugs 58(Suppl. 2):11-18.
25. Raoult, D., M. L. Birg, B. La Scola, P. E. Fournier, M. Enea, H. Lepidi, V. Roux, J. C. Piette, F. Vandenesch, D. Vital Durand, and T. J. Marrie. 2000. Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 342:620-625.
26. Rodriguez, J. C., M. Ruiz, A. Climent, and G. Royo. 2001. In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 17:229-231.
27. Rolain, J. M., L. Stuhl, M. Maurin, and D. Raoult. 2002. Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob, Agents Chemother. 46:2747-2751.
28. Rombel, I. T., K. F. Sykes, S. Rayner, and S. A. Johnston. 2002. ORFFINDER: a vector for high-throughput gene identification. Gene 282:33-41.
29. Vila, J., J. Ruiz, P. Goni, and M. T. De Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coll. Antimicrob. Agents Chemother. 40:491-493.
30. Wang, T., M. Tanaka, and K. Sato. 1998. Detection of grl4 and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob. Agents Chemother. 42:236-240.
31. Waters, B., and J. Davies. 1997. Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics. Antimicrob. Agents Chemother. 41:2766-2769.
32. Weigel, L. M., G. J. Anderson, and F. C. Tenover. 2002. DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. Antimicrob. Agents Chemother. 46:2582-2587.
33. Yagupsky, P. V., D. A. Kaminski, K. M. Palmer, and F. S. Nolte. 1990. Cord formation in BACTEC 7H12 medium for rapid, presumptive identification of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 28:1451-1453.
34. Yoshida, H., T. Kojima, J.-I. Yamagishi, and S. Nakamura. 1988. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet. 211:1-7.